A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of a Single 3 Gram Dose of Cefazolin in Adult Subjects Weighing >= 120 kg Scheduled for Surgery
Phase: PHASE1
Conditions: Infections
Sponsor: B. Braun Medical Inc.

ConﬁdenƟal 
 
B. Braun Medical Inc.  
CLINICAL STUDY PROTOCOL 
 
 
A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of a Single 
3 Gram Dose of Cefazolin in Adult Subjects Weighing ≥120 kg Scheduled for Surgery 
 
 
Protocol Number: US-G-H-2101 
ClinicalTrials.gov Identifier: NCT05205486 
Document Date: 31 August 2021